NXPH4 Promotes Gemcitabine Resistance in Bladder Cancer by Enhancing Reactive Oxygen Species and Glycolysis Activation through Modulating NDUFA4L2

SIMPLE SUMMARY: Bladder cancer is one of the most common malignant tumors of the urinary system, and its treatment is mainly surgical resection, supplemented by chemotherapy after surgery. Postoperative chemotherapy can significantly reduce the tumor recurrence rate and improve the prognosis of blad...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Decai, Zhang, Pu, Liu, Zijian, Xing, Yifei, Xiao, Yajun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367313/
https://www.ncbi.nlm.nih.gov/pubmed/35954445
http://dx.doi.org/10.3390/cancers14153782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367313/
https://www.ncbi.nlm.nih.gov/pubmed/35954445
http://dx.doi.org/10.3390/cancers14153782

Ejemplares similares